HEADER DNA BINDING PROTEIN 28-NOV-22 8FAV TITLE HUMAN RETENOID-RELATED ORPHAN RECEPTOR-GAMMA (RORC2) LIGAND-BINDING TITLE 2 DOMAIN IN COMPLEX WITH COMPOUND 5 ANDINDAZOLE ACID BOUND IN H12- TITLE 3 POCKET COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 5 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 6 ORPHAN RECEPTOR-GAMMA; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RORC2, RORGAMMAT, STRUCTURE-BASED DESIGN, MACROCYCLIZATION, TOPICAL KEYWDS 2 DELIVERY, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR F.F.VAJDOS REVDAT 1 01-MAR-23 8FAV 0 JRNL AUTH M.E.SCHNUTE,J.I.TRUJILLO,K.L.LEE,R.UNWALLA,F.F.VAJDOS, JRNL AUTH 2 B.KAUPPI,P.NUHANT,A.C.FLICK,K.K.CROUSE,Y.ZHAO,A.SAMUEL, JRNL AUTH 3 V.LOMBARDO,A.P.TAYLOR,A.L.BRAULT,J.D.KNAFELS,M.L.VAZQUEZ, JRNL AUTH 4 G.BERSTEIN JRNL TITL MACROCYCLIC RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR JRNL TITL 2 C2 INVERSE AGONISTS. JRNL REF ACS MED.CHEM.LETT. V. 14 191 2023 JRNL REFN ISSN 1948-5875 JRNL PMID 36793423 JRNL DOI 10.1021/ACSMEDCHEMLETT.2C00500 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC V5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 40352 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1964 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4052 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 139 REMARK 3 SOLVENT ATOMS : 290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.68000 REMARK 3 B22 (A**2) : -0.37000 REMARK 3 B33 (A**2) : -0.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.04000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.164 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.148 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.112 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.655 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS U REMARK 3 VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 8FAV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1000270313. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42348 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 96.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: RORG5_IA_DIMER_P21.PDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 5.9, 5 MM AMMONIUM REMARK 280 SULFATE, 300 MM MAGNESIUM CHLORIDE, 10% N,N-DIMETHYLFORMAMIDE, REMARK 280 AND 14% PEG-MME-5000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.46100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 256 REMARK 465 MET A 257 REMARK 465 PRO A 258 REMARK 465 THR A 259 REMARK 465 THR A 508 REMARK 465 GLU A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 SER A 512 REMARK 465 PRO A 513 REMARK 465 VAL A 514 REMARK 465 GLY A 515 REMARK 465 LEU A 516 REMARK 465 SER A 517 REMARK 465 SER B 256 REMARK 465 MET B 257 REMARK 465 PRO B 258 REMARK 465 THR B 259 REMARK 465 THR B 508 REMARK 465 GLU B 509 REMARK 465 THR B 510 REMARK 465 GLU B 511 REMARK 465 SER B 512 REMARK 465 PRO B 513 REMARK 465 VAL B 514 REMARK 465 GLY B 515 REMARK 465 LEU B 516 REMARK 465 SER B 517 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 435 66.67 -110.18 REMARK 500 HIS A 490 75.80 -151.78 REMARK 500 HIS B 490 76.91 -153.56 REMARK 500 REMARK 500 REMARK: NULL DBREF 8FAV A 259 517 UNP P51449 RORG_HUMAN 259 517 DBREF 8FAV B 259 517 UNP P51449 RORG_HUMAN 259 517 SEQADV 8FAV SER A 256 UNP P51449 EXPRESSION TAG SEQADV 8FAV MET A 257 UNP P51449 EXPRESSION TAG SEQADV 8FAV PRO A 258 UNP P51449 EXPRESSION TAG SEQADV 8FAV SER A 278 UNP P51449 CYS 278 ENGINEERED MUTATION SEQADV 8FAV SER A 345 UNP P51449 CYS 345 ENGINEERED MUTATION SEQADV 8FAV SER B 256 UNP P51449 EXPRESSION TAG SEQADV 8FAV MET B 257 UNP P51449 EXPRESSION TAG SEQADV 8FAV PRO B 258 UNP P51449 EXPRESSION TAG SEQADV 8FAV SER B 278 UNP P51449 CYS 278 ENGINEERED MUTATION SEQADV 8FAV SER B 345 UNP P51449 CYS 345 ENGINEERED MUTATION SEQRES 1 A 262 SER MET PRO THR PRO GLU ALA PRO TYR ALA SER LEU THR SEQRES 2 A 262 GLU ILE GLU HIS LEU VAL GLN SER VAL SER LYS SER TYR SEQRES 3 A 262 ARG GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG SEQRES 4 A 262 GLN ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY SEQRES 5 A 262 TYR GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS SEQRES 6 A 262 ALA HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU SEQRES 7 A 262 PHE ALA LYS ARG LEU SER GLY PHE MET GLU LEU SER GLN SEQRES 8 A 262 ASN ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU SEQRES 9 A 262 VAL VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP SEQRES 10 A 262 ASN ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET SEQRES 11 A 262 GLU LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SEQRES 12 A 262 SER ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS SEQRES 13 A 262 PHE SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL SEQRES 14 A 262 LEU ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG SEQRES 15 A 262 LYS VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE SEQRES 16 A 262 HIS HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU SEQRES 17 A 262 ALA LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SEQRES 18 A 262 SER GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU SEQRES 19 A 262 HIS PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR SEQRES 20 A 262 LYS GLU LEU PHE SER THR GLU THR GLU SER PRO VAL GLY SEQRES 21 A 262 LEU SER SEQRES 1 B 262 SER MET PRO THR PRO GLU ALA PRO TYR ALA SER LEU THR SEQRES 2 B 262 GLU ILE GLU HIS LEU VAL GLN SER VAL SER LYS SER TYR SEQRES 3 B 262 ARG GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG SEQRES 4 B 262 GLN ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY SEQRES 5 B 262 TYR GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS SEQRES 6 B 262 ALA HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU SEQRES 7 B 262 PHE ALA LYS ARG LEU SER GLY PHE MET GLU LEU SER GLN SEQRES 8 B 262 ASN ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU SEQRES 9 B 262 VAL VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP SEQRES 10 B 262 ASN ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET SEQRES 11 B 262 GLU LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SEQRES 12 B 262 SER ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS SEQRES 13 B 262 PHE SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL SEQRES 14 B 262 LEU ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG SEQRES 15 B 262 LYS VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE SEQRES 16 B 262 HIS HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU SEQRES 17 B 262 ALA LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SEQRES 18 B 262 SER GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU SEQRES 19 B 262 HIS PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR SEQRES 20 B 262 LYS GLU LEU PHE SER THR GLU THR GLU SER PRO VAL GLY SEQRES 21 B 262 LEU SER HET LKY A 601 34 HET 4Y5 A 602 33 HET SO4 A 603 5 HET LKY B 601 34 HET 4Y5 B 602 33 HETNAM LKY 3-CYANO-N-(3-{[(3S)-4-(CYCLOPENTANECARBONYL)-3- HETNAM 2 LKY METHYLPIPERAZIN-1-YL]METHYL}-5-FLUORO-2-METHYLPHENYL) HETNAM 3 LKY BENZAMIDE HETNAM 4Y5 4-{1-[2-CHLORO-6-(TRIFLUOROMETHYL)BENZOYL]-4-FLUORO-1H- HETNAM 2 4Y5 INDAZOL-3-YL}-3-FLUOROBENZOIC ACID HETNAM SO4 SULFATE ION FORMUL 3 LKY 2(C27 H31 F N4 O2) FORMUL 4 4Y5 2(C22 H10 CL F5 N2 O3) FORMUL 5 SO4 O4 S 2- FORMUL 8 HOH *290(H2 O) HELIX 1 AA1 SER A 266 THR A 284 1 19 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 ARG A 310 1 10 HELIX 5 AA5 SER A 312 LEU A 338 1 27 HELIX 6 AA6 SER A 345 MET A 365 1 21 HELIX 7 AA7 GLY A 384 GLY A 392 5 9 HELIX 8 AA8 CYS A 393 ALA A 409 1 17 HELIX 9 AA9 SER A 413 ILE A 426 1 14 HELIX 10 AB1 GLU A 435 THR A 457 1 23 HELIX 11 AB2 ARG A 459 LEU A 466 5 8 HELIX 12 AB3 GLY A 470 HIS A 490 1 21 HELIX 13 AB4 PHE A 498 SER A 507 1 10 HELIX 14 AB5 SER B 266 GLU B 283 1 18 HELIX 15 AB6 ARG B 288 GLN B 295 1 8 HELIX 16 AB7 ARG B 296 ASN B 298 5 3 HELIX 17 AB8 SER B 301 ARG B 310 1 10 HELIX 18 AB9 SER B 312 LEU B 338 1 27 HELIX 19 AC1 SER B 345 MET B 365 1 21 HELIX 20 AC2 GLY B 384 GLY B 392 5 9 HELIX 21 AC3 CYS B 393 ALA B 409 1 17 HELIX 22 AC4 SER B 413 ILE B 426 1 14 HELIX 23 AC5 GLU B 435 THR B 457 1 23 HELIX 24 AC6 ARG B 459 LEU B 466 5 8 HELIX 25 AC7 PRO B 468 HIS B 490 1 23 HELIX 26 AC8 PHE B 498 SER B 507 1 10 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378 SSBOND 1 CYS A 455 CYS B 455 1555 1555 2.05 CRYST1 47.088 96.922 56.914 90.00 91.26 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021237 0.000000 0.000466 0.00000 SCALE2 0.000000 0.010318 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017575 0.00000